SpringTide Ventures Names Brad Otto and Claire Smith as Partners to Fuel Continued Expansion
May 22 2024 - 11:15AM
Business Wire
SpringTide Ventures, a leader in early-stage HealthTech venture
capital, today announced the appointment of Brad Otto and Claire
Smith as full partners, marking a significant enhancement in the
firm’s strategic leadership. This move aligns with SpringTide’s
vision for pioneering investments in emerging technologies.
“Claire’s deep background and expertise in the emerging
technologies we are investing in is pivotal, aligning perfectly
with our firm’s genetic makeup and emphasizing the critical role of
technologists in early-stage investing. This focus ensures that we
do not stray from our core mission of tech investing,” says Austin
Walters, managing partner at SpringTide. “Similarly, Brad’s deep
industry understanding and background in health insurance and
venture capital equips us with a robust foundation for managing
complex investments and navigating the nuances of early-stage
healthcare.”
Before SpringTide, Otto worked on the corporate venture capital
team at UnitedHealth Group, where he worked to scale health tech
companies like Orthology and Sanvello Health.
“SpringTide has a unique opportunity to partner with founders
who are really interested in making a positive impact on healthcare
and disrupting the status quo,” said Otto. “I am glad to be a part
of a team where I can make a difference.”
Prior to SpringTide, Smith was an investor at Meridian Street
Capital and Anterra Capital, focusing on seed-stage health tech and
agri tech. She also served as Chief of Staff at Crestovo, a
microbiome therapeutics startup later acquired by Finch
Therapeutics.
"I love working with founders and being able to translate ideas
into products that help people. SpringTide has empowered this
reality," said Smith. "Joining this team was a pivotal decision
driven by my desire to delve deeper into early-stage healthcare and
deep tech, particularly within the TechBio sphere."
Brad and Claire will assume key responsibilities in capital
formation, deal-making, and portfolio governance. “Claire and Brad
are exemplary builders who embody SpringTide’s pioneering spirit,”
said Walters. “They have already proven that they excel in finding
and supporting founders with the desire and vision to disrupt
healthcare, and we are already hard at work.”
For more information about SpringTide Ventures, visit
https://springtide.com/.
About SpringTide Ventures
SpringTide Ventures is an investment firm dedicated to
supporting the world’s best healthcare innovators. Based in Boston,
Salt Lake City, and San Francisco, the firm currently has $100
million in total assets under management, focusing on early-stage
investments in digital health, medical devices, life sciences, and
tech-enabled care delivery. For more information, visit
https://springtide.com/.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240522406174/en/
Josh Heath josh@springtide.com